Respiratory diseases are defined as
the diseases that affect the nasal passage, air passage, lungs and the bronchi.
Respiratory diseases range from acute condition such as common cold, pneumonia,
bronchitis to chronic conditions such as chronic pulmonary obstructive diseases
(COPD) and asthma. Onset of respiratory infection is provoked by number of
causative agent’s namely viral pathogens, bacterial pathogens, smoking, allergens
and occupational agents.
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/respiratory-disease-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018
As cited by World Health
Organization (WHO), respiratory disease has become one of the most common
causes of deaths worldwide. Complications in breathing severely affect the
quality of life of the patients and so rising prevalence of respiratory
diseases across the globe possesses a serious threat. Asthma, a chronic disease
characterized by recurrent attacks of breathlessness and COPD is a life
threatening lung disease that interferes with the normal breathing. It has been
estimated that currently, more than 235 million people are suffering from
asthma and about 64 million people are diagnosed with COPD. Nowadays,
occurrence of respiratory diseases is common in both the gender owing to
increased usage of tobacco and exposure to smoke of biomass fuels used for
cooking.
People suffering from the
respiratory diseases require healthcare services from primary consultations to
hospital admission. Thus, with the increase in demand for treatment of
respiratory diseases manufactures are developing testing devices which can
diagnose the diseases at an early stage. Simple diagnostic tests such as
spirometer, peak flow meters, polysomnography devices and other diagnostic
devices are available in the market to cater the unmet needs. For further
controlling the mortality rate companies are entering into collaborations for
launching diagnostic tests. Usages of these tests are procured by hospitals,
physician’s offices, private/commercial labs and public health labs.
North America accounts for a larger
share among all the geographies followed by Europe owing to increase in aging
population, smoking and rising incidences of common COPD. However, due to
increase in smoking rate, Asian countries also holds a significant share in
respiratory disease testing market.
The emergence in this market is
expected to show a double digit growth in the coming years owing to demographic
changes, increase in the COPD cases and technological advancements which will
influence the growth of this market. In addition with the growing demand for
long term treatment and managing the condition acts as a driver for the growth
of this market. Some of the key players in the respiratory diseases testing
market include Abott, Beckman Coulter, affymetrix, biomeriux and others.
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
About Us
MarketResearchReports.Biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research, subscription
access and consulting services. We serve all sizes and types of companies
spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment